Specific frequency band of amplitude low-frequency fl{ligature}uctuation predicts Parkinson's disease

Behavioural Brain Research

Volumn 252, Issue , 2013, Pages 18-23

  Zhang, Jiuquan ^a   Wei, Luqing ^a   Hu, Xiaofei ^a   Zhang, Yanling ^a   Zhou, Daiquan ^a   Li, Chuan ^a   Wang, Xin ^a   Feng, Hua ^a   Yin, Xuntao ^a   Xie, Bin ^a   Wang, Jian ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Amplitude low frequency fl ligature uctuation; Corticostriatal network; Parkinson's disease; Resting state functional magnetic resonance imaging

Indexed keywords

ADULT; AMPLITUDE LOW FREQUENCY FLUCTUATION; ARTICLE; BOLD SIGNAL; BRAIN ELECTROPHYSIOLOGY; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE COURSE; FEMALE; FREQUENCY MODULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NERVE CELL NETWORK; OCCIPITAL CORTEX; PARIETAL CORTEX; PARKINSON DISEASE; PATHOPHYSIOLOGY; PREDICTION; PRIORITY JOURNAL; TEMPORAL CORTEX; THALAMUS;

AMPLITUDE LOW-FREQUENCY FLUCTUATION; CORTICOSTRIATAL NETWORK; PARKINSON'S DISEASE; RESTING-STATE FUNCTIONAL MAGNETIC RESONANCE IMAGING;

AGED; BRAIN; BRAIN MAPPING; FEMALE; FUNCTIONAL LATERALITY; HEAD MOVEMENTS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OXYGEN; PARKINSON DISEASE; PREDICTIVE VALUE OF TESTS;

EID: 84879406840     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2013.05.039     Document Type: Article

References (75)

1. Jankovic J. Parkinson's disease: clinical features and diagnosis. Journal of Neurology, Neurosurgery & Psychiatry 2008, 79:368-376.
2. Damier P., Hirsch E., Agid Y., Graybiel A. The substantia nigra of the human brain II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. Brain 1999, 122:1437-1448.
3. Alexander G.E., DeLong M.R., Strick P.L. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annual Review of Neuroscience 1986, 9:357-381.
4. Albin R.L., Young A.B., Penney J.B. The functional anatomy of basal ganglia disorders. Trends in Neurosciences 1989, 12:366-375.
5. Berardelli A., Rothwell J., Thompson P.D., Hallett M. Pathophysiology of bradykinesia in Parkinson's disease. Brain 2001, 124:2131-2146.
6. Mink J.W. The basal ganglia and involuntary movements: impaired inhibition of competing motor patterns. Archives of Neurology 2003, 60:1365.
7. Huang C., Tang C., Feigin A., Lesser M., Ma Y., Pourfar M., et al. Changes in network activity with the progression of Parkinson's disease. Brain 2007, 130:1834-1846.
8. Eckert T., Barnes A., Dhawan V., Frucht S., Gordon M.F., Feigin A.S., et al. FDG PET in the differential diagnosis of parkinsonian disorders. NeuroImage 2005, 26:912-921.
9. Fukuda M., Edwards C., Eidelberg D. Functional brain networks in Parkinson's disease. Parkinsonism & Related Disorders 2001, 8:91.
10. Eidelberg D., Moeller J.R., Ishikawa T., Dhawan V., Spetsieris P., Chaly T., et al. Assessment of disease severity in parkinsonism with fluorine-18-fluorodeoxyglucose and PET. Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine 1995, 36:378.
11. Tang C.C., Poston K.L., Dhawan V., Eidelberg D. Abnormalities in metabolic network activity precede the onset of motor symptoms in Parkinson's disease. The Journal of Neuroscience 2010, 30:1049-1056.
12. Lin T.P., Carbon M., Tang C., Mogilner A.Y., Sterio D., Beric A., et al. Metabolic correlates of subthalamic nucleus activity in Parkinson's disease. Brain 2008, 131:1373-1380.
13. Hacker C.D., Perlmutter J.S., Criswell S.R., Ances B.M., Snyder A.Z. Resting state functional connectivity of the striatum in Parkinson's disease. Brain 2012, 135:3699-3711.
14. Tessitore A., Amboni M., Esposito F., Russo A., Picillo M., Marcuccio L., et al. Resting-state brain connectivity in patients with Parkinson's disease and freezing of gait. Parkinsonism & related disorders 2012, 18:781-787.
15. Skidmore F., Yang M., Baxter L., Von Deneen K., Collingwood J., He G., et al. Reliability analysis of the resting state can sensitively and specifically identify the presence of Parkinson disease. NeuroImage 2013, 75:249-261.
16. Kwak Y., Peltier S., Bohnen N.I., Müller M.L.T.M., Dayalu P., Seidler R.D. L-DOPA changes spontaneous low-frequency BOLD signal oscillations in Parkinson's disease: a resting state fMRI study. Frontiers in Systems Neuroscience 2012, 6:52.
17. Baudrexel S., Witte T., Seifried C., von Wegner F., Beissner F., Klein J.C., et al. Resting state fMRI reveals increased subthalamic nucleus-motor cortex connectivity in Parkinson's disease. NeuroImage 2011, 55:1728-1738.
18. Wu T., Long X., Wang L., Hallett M., Zang Y., Li K., et al. Functional connectivity of cortical motor areas in the resting state in Parkinson's disease. Human Brain Mapping 2011, 32:1443-1457.
19. Helmich R.C., Derikx L.C., Bakker M., Scheeringa R., Bloem B.R., Toni I. Spatial remapping of cortico-striatal connectivity in Parkinson's disease. Cerebral Cortex 2010, 20:1175-1186.
20. Kwak Y., Peltier S., Bohnen N., Müller M., Dayalu P., Seidler R.D. Altered resting state cortico-striatal connectivity in mild to moderate stage Parkinson's disease. Frontiers in Systems Neuroscience 2010, 4:143.
21. Wu T., Long X., Zang Y., Wang L., Hallett M., Li K., et al. Regional homogeneity changes in patients with Parkinson's disease. Human Brain Mapping 2009, 30:1502-1510.
22. Buzsáki G., Draguhn A. Neuronal oscillations in cortical networks. Science 2004, 304:1926-1929.
23. Penttonen M., Buzsáki G. Natural logarithmic relationship between brain oscillators. Thalamus & Related Systems 2003, 2:145-152.
24. Zuo X.N., Di Martino A., Kelly C., Shehzad Z.E., Gee D.G., Klein D.F., et al. The oscillating brain: complex and reliable. NeuroImage 2010, 49:1432-1445.
25. Han Y., Wang J., Zhao Z., Min B., Lu J., Li K., et al. Frequency-dependent changes in the amplitude of low-frequency fluctuations in amnestic mild cognitive impairment: a resting-state fMRI study. NeuroImage 2010, 55:287-295.
26. Baria A.T., Baliki M.N., Parrish T., Apkarian A.V. Anatomical and functional assemblies of brain BOLD oscillations. The Journal of Neuroscience 2011, 31:7910-7919.
27. Di Martino A., Ghaffari M., Curchack J., Reiss P., Hyde C., Vannucci M., et al. Decomposing intra-subject variability in children with attention-deficit/hyperactivity disorder. Biological Psychiatry 2008, 64:607-614.
28. Hoptman M.J., Zuo X.N., Butler P.D., Javitt D.C., D'Angelo D., Mauro C.J., et al. Amplitude of low-frequency oscillations in schizophrenia: a resting state fMRI study. Schizophrenia Research 2010, 117:13-20.
29. Han Y., Lui S., Kuang W., Lang Q., Zou L., Jia J. Anatomical and functional deficits in patients with amnestic mild cognitive impairment. PLoS One 2012, 7:e28664.
30. Liang X., Wang J., Yan C., Shu N., Xu K., Gong G., et al. Effects of different correlation metrics and preprocessing factors on small-world brain functional networks: a resting-state functional MRI study. PLoS One 2012, 7:e32766.
31. Wei L., Duan X., Zheng C., Wang S., Gao Q., Zhang Z., et al. Specific frequency bands of amplitude low-frequency oscillation encodes personality. Human Brain Mapping 2012, [Epub ahead of print]. 10.1002/hbm.22176.
32. Wu T., Hallett M. A functional MRI study of automatic movements in patients with Parkinson's disease. Brain 2005, 128:2250-2259.
33. Biswal B., Yetkin F., Haughton V., Hyde J. Functional connectivity in the motor cortex of resting human brain using echo-planar MRI. Magnetic Resonance in Medicine 1995, 34:537-541.
34. Oldfield R.C. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 1971, 9:97-113.
35. Hughes A.J., Daniel S.E., Kilford L., Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. Journal of Neurology, Neurosurgery & Psychiatry 1992, 55:181-184.
36. Fahn S., Elton R. Unified Parkinson's disease rating scale. Recent Developments in Parkinson's Disease 1987, 2:153-163. Committee U.D.
37. Satterthwaite T.D., Wolf D.H., Loughead J., Ruparel K., Elliott M.A., Hakonarson H., et al. Impact of in-scanner head motion on multiple measures of functional connectivity: relevance for studies of neurodevelopment in youth. NeuroImage 2012, 60:623-632.
38. Ashburner J., Friston K. Unified Segmentation. NeuroImage 2005, 26:839-851.
39. Zang Y., Yong H., Chao-Zhe Z., Qing-Jiu C., Man-Qiu S., Meng L., et al. Altered baseline brain activity in children with ADHD revealed by resting-state functional MRI. Brain and Development 2007, 29:83-91.
40. Power J.D., Barnes K.A., Snyder A.Z., Schlaggar B.L., Petersen S.E. Spurious but systematic correlations in functional connectivity MRI networks arise from subject motion. NeuroImage 2011, 50:2142-2154.
41. Van Dijk K.R.A., Sabuncu M.R., Buckner R.L. The influence of head motion on intrinsic functional connectivity MRI. NeuroImage 2011, 59:431-438.
42. Bhatia K.P., Marsden C.D. The behavioural and motor consequences of focal lesions of the basal ganglia in man. Brain 1994, 117:859-876.
43. Rinne J.O., Portin R., Ruottinen H., Nurmi E., Bergman J., Haaparanta M., et al. Cognitive impairment and the brain dopaminergic system in Parkinson disease: [18F] fluorodopa positron emission tomographic study. Archives of Neurology 2000, 57:470.
44. Jokinen P., Brück A., Aalto S., Forsback S., Parkkola R., Rinne J.O. Impaired cognitive performance in Parkinson's disease is related to caudate dopaminergic hypofunction and hippocampal atrophy. Parkinsonism & Related Disorders 2009, 15:88-93.
45. Holthoff-Detto V.A., Kessler J., Herholz K., Bonner H., Pietrzyk U., Wurker M., et al. Functional effects of striatal dysfunction in Parkinson disease. Archives of Neurology 1997, 54:145.
46. Holthoff V., Vieregge P., Kessler J., Pietrzyk U., Herholz K., Bönner J., et al. Discordant twins with Parkinson's disease: positron emission tomography and early signs of impaired cognitive circuits. Annals of Neurology 1994, 36:176-182.
47. Lisanby S., McDonald W., Massey E., Doraiswamy P., Rozear M., Boyko O., et al. Diminished subcortical nuclei volumes in Parkinson's disease by MR imaging. Journal of Neural Transmission Supplementum 1993, 40:13.
48. Pitcher T.L., Melzer T.R., MacAskill M.R., Graham C.F., Livingston L., Keenan R.J., et al. Reduced striatal volumes in Parkinson's disease: a magnetic resonance imaging study. Translational Neurodegeneration 2012, 1:17.
49. Melzer T.R., Watts R., MacAskill M.R., Pitcher T.L., Livingston L., Keenan R.J., et al. Grey matter atrophy in cognitively impaired Parkinson's disease. Journal of Neurology, Neurosurgery & Psychiatry 2012, 83:188-194.
50. Oishi N., Udaka F., Kameyama M., Sawamoto N., Hashikawa K., Fukuyama H. Regional cerebral blood flow in Parkinson disease with nonpsychotic visual hallucinations. Neurology 2005, 65:1708-1715.
51. Lyoo C.H., Ryu Y.H., Lee M.S. Cerebral cortical areas in which thickness correlates with severity of motor deficits of Parkinson's disease. Journal of Neurology 2011, 258:1871-1876.
52. Lyoo C.H., Ryu Y.H., Lee M.S. Topographical distribution of cerebral cortical thinning in patients with mild Parkinson's disease without dementia. Movement Disorders 2010, 25:496-499.
53. Ramírez-Ruiz B., Martí M.J., Tolosa E., Gimenez M., Bargallo N., Valldeoriola F., et al. Cerebral atrophy in Parkinson's disease patients with visual hallucinations. European Journal of Neurology 2007, 14:750-756.
54. Mayberg H.S., Starkstein S.E., Sadzot B., Preziosi T., Andrezejewski P.L., Dannals R.F., et al. Selective hypometabolism in the inferior frontal lobe in depressed patients with Parkinson's disease. Annals of Neurology 2004, 28:57-64.
55. Wu T., Hallett M. The cerebellum in Parkinson's disease. Brain 2013, 136:696-709.
56. Hilker R., Schweitzer K., Coburger S., Ghaemi M., Weisenbach S., Jacobs A.H., et al. Nonlinear progression of Parkinson disease as determined by serial positron emission tomographic imaging of striatal fluorodopa F 18 activity. Archives of Neurology 2005, 62:378.
57. Jankovic J. Progression of Parkinson disease: are we making progress in charting the course?. Archives of Neurology 2005, 62:351.
58. Catalan M.J., Ishii K., Honda M., Samii A., Hallett M. A PET study of sequential finger movements of varying length in patients with Parkinson's disease. Brain 1999, 122:483-495.
59. Lewis M.M., Slagle C.G., Smith D.B., Truong Y., Bai P., McKeown M., et al. Task specific influences of Parkinson's disease on the striato-thalamo-cortical and cerebello-thalamo-cortical motor circuitries. Neuroscience 2007, 147:224.
60. Rascol O., Sabatini U., Fabre N., Brefel C., Loubinoux I., Celsis P., et al. The ipsilateral cerebellar hemisphere is overactive during hand movements in akinetic parkinsonian patients. Brain 1997, 120:103-110.
61. Yu H., Sternad D., Corcos D.M., Vaillancourt D.E. Vaillancourt, Role of hyperactive cerebellum and motor cortex in Parkinson's disease. NeuroImage 2007, 35:222-233.
62. Abe Y., Kachi T., Kato T., Arahata Y., Yamada T., Washimi Y., et al. Occipital hypoperfusion in Parkinson's disease without dementia: correlation to impaired cortical visual processing. Journal of Neurology, Neurosurgery & Psychiatry 2003, 74:419-422.
63. Bohnen N., Minoshima S., Giordani B., Frey K., Kuhl D. Motor correlates of occipital glucose hypometabolism in Parkinson's disease without dementia. Neurology 1999, 52:541-546.
64. Hu M., Taylor-Robinson S., Chaudhuri K.R., Bell J., Labbe C., Cunningham V., et al. Cortical dysfunction in non-demented Parkinson's disease patients A combined 31P-MRS and 18FDG-PET study. Brain 2000, 123:340-352.
65. Mentis M.J., McIntosh A.R., Perrine K., Dhawan V., Berlin B., Feigin A., et al. Relationships among the metabolic patterns that correlate with mnemonic, visuospatial, and mood symptoms in Parkinson's disease. American Journal of Psychiatry 2002, 159:746-754.
66. Evarts E., Kimura M., Wurtz R., Hikosaka O. Behavioral correlates of activity in basal ganglia neurons. Trends in Neurosciences 1984, 7:447-453.
67. Planetta P., Schulze E., Geary E., Corcos D., Goldman J., Little D., et al. Thalamic projection fiber integrity in de novo Parkinson disease. American Journal of Neuroradiology 2012, 34:74-79.
68. McKeown M.J., Uthama A., Abugharbieh R., Palmer S., Lewis M., Huang X. Shape (but not volume) changes in the thalami in Parkinson disease. BMC Neurology 2008, 8:8.
69. Prodoehl J., Spraker M., Corcos D., Comella C., Vaillancourt D. Blood oxygenation level-dependent activation in basal ganglia nuclei relates to specific symptoms in de novo Parkinson's disease. Movement Disorders 2010, 25:2035-2043.
70. Pifl C., Kish S.J., Hornykiewicz O. Thalamic noradrenaline in Parkinson's disease: deficits suggest role in motor and non-motor symptoms. Movement Disorders 2012, 27:1618-1624.
71. Halliday G.M. Thalamic changes in Parkinson's disease. Parkinsonism & Related Disorders 2009, 15:152-155.
72. Rüb U., Del Tredici K., Schultz C., Ghebremedhin E., De Vos R., Jansen Steur E., et al. Parkinson's disease: the thalamic components of the limbic loop are severely impaired by α-synuclein immunopositive inclusion body pathology. Neurobiology of aging 2002, 23:245-254.
73. Braak H., Tredici K.D., Rüb U., de Vos R.A., ansen Steur J.E.N., Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiology of aging 2003, 24:197-211.
74. Nagamachi S., Wakamatsu H., Kiyohara S., Fujita S., Futami S., Tamura S., et al. Usefulness of rCBF analysis in diagnosing Parkinson's disease: supplemental role with MIBG myocardial scintigraphy. Annals of Nuclear Medicine 2008, 22:557-564.
75. Jubault T., Gagnon J.F., Karama S., Ptito A., Lafontaine A.L., Evans A.C., et al. Patterns of cortical thickness and surface area in early Parkinson's disease. NeuroImage 2011, 55:462-467.